
On May 14, 2025, the U.S. Food and Drug Administration (FDA) approved Welireg (belzutifan), developed by Merck & Co., Inc., for the treatment of adults and….
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Emrelis (telisotuzumab vedotin), AbbVie’s investigational antibody-drug…..
A large nationwide study from South Korea has uncovered a significantly higher risk of developing Autoimmune Rheumatic Diseases (ARDs) in people living with….
The European Commission has granted orphan drug designation to ERapa, a promising investigational therapy developed by Reata Pharmaceuticals, for the…..
A cutting-edge advancement in synthetic chemistry has emerged with the development of a technique that allows scientists to add a single carbon atom during…..